Baird Chautauqua funds navigated a complex Q4 2025 marked by international outperformance and shifting central bank policies.

Outlook Therapeutics believes this determination is inconsistent with the totality of evidence submitted in the BLA, including data from an adequate and well-controlled study and confirmatory evidence ...

PG&E Corporation has reported its full-year 2025 results, with revenue rising to US$24,935 million and net income reaching US$2,593 million, alongside modestly higher earnings per share versus 2024.

CBO projects that the shortfall will deepen in 2026 to $1.853 trillion, slightly more than 2025’s $1.775 trillion deficit. Looking further down the road offers a similarly concerning trajectory. Over ...

Moody's downgrade of the banking sector outlook is in line with the change in Indonesia's credit rating outlook from stable ...

A durable coalition will be critical to Thailand's post-election fiscal outlook and would help reduce the risk of a sovereign ...

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina ...

Curis is back on investors’ radar after analysts reaffirmed a US$14.00 fair value per share, while quietly adjusting some of the key assumptions that sit behind that number. The discount rate shift to ...

XRP trades near $1.35 as Ripple CEO joins CFTC panel, with controlled selling and key resistance at $1.76 shaping recovery outlook.

For years, L.A.’s private equity and finance scene has buzzed with pent-up capital. Dealmakers have long awaited greener pastures: lower interest rates, a ...

Canada’s auto production has fallen sharply over the past decade as EV policy shifts and Japanese automakers expand their footprint.

Investing.com -- dsm-firmenich AG (EURONEXT:DSFIR) on Thursday reported mixed fourth-quarter results with organic sales ...